Article ID Journal Published Year Pages File Type
8964506 Clinical Oncology 2018 9 Pages PDF
Abstract
Utilisation of new targeted drugs and immune therapies for MM has increased considerably in routine practice 2007-2015. Consistent with the results of clinical trials, adoption was associated with substantial increases in survival of patients in the general population.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , ,